ProfileGDS4718 / 228107_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 25% 22% 81% 26% 30% 32% 30% 26% 27% 33% 28% 29% 31% 31% 31% 38% 30% 29% 34% 26% 27% 27% 32% 30% 26% 29% 30% 27% 33% 29% 22% 46% 24% 33% 31% 33% 26% 24% 32% 80% 25% 32% 34% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.3288325
GSM549102patient 115, normal, homogenized [OPG study]4.2273522
GSM549104patient 119, normal, homogenized [OPG study]8.0994681
GSM549108patient 138, normal, homogenized [OPG study]4.4388926
GSM549119patient 077, normal, homogenized [OPG study]4.562330
GSM549133patient 032, cancer, homogenized [OPG study]4.5722132
GSM549139patient 042, cancer, homogenized [OPG study]4.5105430
GSM549099patient 107, normal, homogenized [OPG study]4.4002726
GSM549109patient 139, normal, homogenized [OPG study]4.4462827
GSM549110patient 046, normal, homogenized [OPG study]4.6678633
GSM549114patient 063, normal, homogenized [OPG study]4.4306828
GSM549122patient 082, normal, homogenized [OPG study]4.5099429
GSM549134patient 033, cancer, homogenized [OPG study]4.569431
GSM549136patient 036, cancer, homogenized [OPG study]4.5018531
GSM549140patient 044, cancer, homogenized [OPG study]4.5535731
GSM549111patient 047, normal, homogenized [OPG study]4.8819238
GSM549113patient 057, normal, homogenized [OPG study]4.4756530
GSM549132patient 031, cancer, homogenized [OPG study]4.4988229
GSM549137patient 038, cancer, homogenized [OPG study]4.6782534
GSM549142patient 047, cancer, homogenized [OPG study]4.4793826
GSM549100patient 110, normal, homogenized [OPG study]4.4238527
GSM549107patient 135, normal, homogenized [OPG study]4.4051427
GSM549115patient 068, normal, homogenized [OPG study]4.5534432
GSM549116patient 072, normal, homogenized [OPG study]4.5078430
GSM549120patient 078, normal, homogenized [OPG study]4.3803626
GSM549131patient 030, cancer, homogenized [OPG study]4.4481129
GSM549118patient 074, normal, homogenized [OPG study]4.5461730
GSM549129patient 027, cancer, homogenized [OPG study]4.4329527
GSM549123patient 088, normal, homogenized [OPG study]4.6397733
GSM549124patient 006, cancer, homogenized [OPG study]4.5271329
GSM549126patient 015, cancer, homogenized [OPG study]4.2192722
GSM549128patient 025, cancer, homogenized [OPG study]5.2905146
GSM549103patient 117, normal, homogenized [OPG study]4.3519324
GSM549117patient 073, normal, homogenized [OPG study]4.6560133
GSM549138patient 041, cancer, homogenized [OPG study]4.5707731
GSM549141patient 045, cancer, homogenized [OPG study]4.5955233
GSM549130patient 028, cancer, homogenized [OPG study]4.3887226
GSM549101patient 111, normal, homogenized [OPG study]4.3138924
GSM549105patient 128, normal, homogenized [OPG study]4.6664432
GSM549106patient 134, normal, homogenized [OPG study]7.9891280
GSM549112patient 048, normal, homogenized [OPG study]4.3217825
GSM549125patient 011, cancer, homogenized [OPG study]4.628732
GSM549127patient 024, cancer, homogenized [OPG study]4.7110834
GSM549135patient 035, cancer, homogenized [OPG study]4.717735